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Introduction
Biomaterials and their associated medical devices are an important future technology, both
in terms of their health care capabilities and the opportunities they present for wealth
creation. Biomaterials development is essentially a multidisciplinary activity.
In orthopaedic or dental surgery, most prostheses are made with metal or metallic alloys.
A successful long-term implant requires biocompatibility, toughness, strength, corrosion
resistance, wear resistance and fracture resistance [1]. Three groups of metal prevail for
clinical application[2]: stainless steels, cobalt-based alloys and titanium or titanium alloys.
Nevertheless, metal, in contact with body fluids, forms corrosion products which cause
different tissue reactions according to the metal. A metallic contamination surrounding
tissues may play a major role in aseptic loosening of the implant. A way to prevent this
problem of corrosion is to use a biomaterial coating. A layer thickness of few tens of
micrometers allows to isolate the implant from the corrosive environment during some
months, to confer the layer biocompatibility on the prosthesis and to keep the mechanical
properties of the supporting metal. Such as hydroxyapatites ceramics, biological glasses
are good candidates for coating metallic prostheses. In contact with cell tissue, they show
in vivo and in vitro biocompatibility, no inflammatory and no toxic processes. They can
be bioactive or bioinert according to their composition in oxides. The bioactive fixation
is defined as an interfacial bond between implant and tissues by means of formation of a
biologically active hydroxyapatite layer on the implant surface [3].
We have studied two different glasses marked off BVA and BVH. Both glasses are used
as coating of titanium alloy prostheses (Ti6Al4V). Several methods have been performed
in these studies such as nuclear and physico-chemical techniques. The implant with its
coating is in contact either with trabecular bone or with lacuna site.
Materials
Glasses are manufactured [4] by melting the components and heating them between 1300 ◦C
and 1600 ◦C. They are cast, crushed and transformed into powder of grain suitable to the
spraying process. They are deposited on sand blasted Ti6Al4V cylinders, 18 mm in length
and 4 mm in diameter. The compositions are shown on table 1.
SiO2 Na2O CaO P2O5 K2O Al2O3 MgO
BVA 47 % 19 % 20 % 7 % 5 % 1 % 1 %
BVH 71 % 14 % 9 % – 1 % 2 % 3 %
Table 1: Composition (% wt) of biological glasses : BVA & BVH.
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The coating constists of small granules linked together in an heterogeneous and non
continuous form which provides a favorable surface for the attachment of bone tissue. The
thickness ranges from 30 to 100 µm.
The rods are implanted into lateral femoral epiphisis of sheep by manual pressure. The
animals are sacrified at 3, 6 and 12 months after implantation. The samples are embedded
in PMMA resin and cut in transversal sections of 400 µm thickness.
Methods
Scanning Electron Microscopy (SEM), Scanning Transmission Electron Microscopy (STEM)
and Energy Dispersive X-ray Spectroscopy (EDXS) are used firstly for a qualitative and
quantitative analysis of the coatings according to the implantation duration. For STEM
and EDXS, some samples are cut into ultra-thin sections of about 100 nm with a diamond
ultra-microtome. Bony tissues and coating are also studied simoultaneously by Particle
Induced X-ray Emission (PIXE) and Rutherford Backscattering Spectrometry (RBS) with
nuclear micro-probe (protons of energy 3 MeV, intensity 600 pA and 5 µm beam diameter).
PIXE is performed to identify trace elements and to cartography their repartition and RBS
to determine organic matrix composition and to measure the electric charge received by
the sample during irradiation. This experimental setup has been published elsewhere [5][6].
Results and discussion
With BVA and when the coating is in contact with trabecular bone, there is gel formation
relatively dense and homogeneous. When the coating is in contact with lacuna site, this
gel has different densities and is heterogeneous. The BVA glass proved to be bioactive:
it is transformed into a silicon gel with incorporation of protein and trace elements: Zn
and Sr. This gel disappears gradually and is replaced by neoformed bone at 6 months
after implantation. These transformations lead to a better osseointegration of the coated
implant than uncoated prostheses [7]. Bony contact perimeter is increased, then BVA glass
permits to limit micro-motion of the implant.
The BVH glass is bioinert: there is no gel formation. Its composition is constant
versus time. However, the formation of a 2 µm thickness interface, induced by plasma
spray coating process, weakens the inter-granular connections. This fact results in the
fragmentation of the coating and the migration of glass particules through the lacunar
network of surrounding bone. Its expected function is to protect metallic prosthesis against
corrosion: BVH coating is used like a cement.
In table 2, we present mean titanium concentration values measured in surrounding
bone of the implant for each kind of coating and for the three implantation durations. In
the case of uncoated implants, we found that after a period of establishment, the titanium
contamination in bony tissue is constant (about 1200 ppm). This result is consistent
with the observation of Agins [8]. We consider that the two glasses protect efficiently
the implanted metallic prostheses against the corrosion since we do not detect titanium
in bone directly in contact with glass (table 2). In the same time, coating glasses can
be contaminated themselves by metallic elements coming from the metallic prosthesis. In
both glass coating, we have detected titanium contamination. But, as mentioned above,
BVA glass completely disappears between 3 and 6 months after implantation and BVH
glass is gradually detached from the prosthesis. Then a large part of prosthesis surface
becomes uncoated and the corrosion begins. And after 12 months of implantation, the
titanium amounts in bony tissue directly in contact with metal of uncoated and initially
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3 months 6 months 12 months
bone directly in con-
tact with prosthesis
initially coated with
BVA
– 285 ± 14 888 ± 86
bone directly in con-
tact with prosthesis
initially coated with
BVH
– 387 ± 246 1307 ± 167
bone directly in con-
tact with the glass
(BVA or BVH)
< LOD < LOD < LOD
bone directly in con-
tact with prosthesis
initially uncoated
651 ± 26 1221 ± 99 1134 ± 67
Table 2: Titanium concentration in ppm (LOD = Limit Of Detection).
coated prosthesis are similar. The protective effect of glasses is thus effictive as a long
time as glasses remain in place. If we look to the contamination away from the edge of the
implant, we observe that it is concentrated in the first 100 µm and that it decreases fastly
after some hundred micrometers (fig. 1).
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Figure 1: Profile of titanium contamination of bony tissue surrounding an uncoated implant
after 12 months of implantation.
Conclusion
The two glasses have different behaviour during the first months after their implantation
in the body. However, they prevent metallic contamination of surrounding tissues. One
year after implantation, BVA is resorbed and BVH is destroyed into debris and the con-
tamination from metallic prosthesis began.
3
It is shown that the bioactive glass BVA coating enhances the osseointegration of a
metallic implant: this is an advantage in the first months after surgery. On the other
hand, the plasma spraying at high temperature can induce surface modification and we
look after an alternative technique.
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